Recombinant KIR2DL2 (Lirilumab Biosimilar) antibody

Catalog No. ABIN7538062

This anti-KIR2DL2 (Lirilumab Biosimilar) antibody is a Human Monoclonal antibody detecting KIR2DL2 (Lirilumab Biosimilar) in ELISA and WB. Suitable for Human.

Quick Overview for Recombinant KIR2DL2 (Lirilumab Biosimilar) antibody (ABIN7538062)

Target: KIR2DL2 (Lirilumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This KIR2DL2 (Lirilumab Biosimilar) antibody is un-conjugated

Application: ELISA, Western Blotting (WB)

Grade: Research Grade

Product Details anti-KIR2DL2 (Lirilumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Lirilumab Biosimilar - Anti-KIRD2 subgroup mAb - Research Grade

Characteristics: Antibody Type: Human IgG1

Purification: Recombinant antibody expressed in mammalien cells and purified.

Purity: > 85%

Isotype: IgG

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS buffer PH7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for KIR2DL2 (Lirilumab Biosimilar)

Target: KIR2DL2 (Lirilumab Biosimilar)

Background: Lirilumab is an anti-KIR monoclonal antibody, and shows antitumor activity. Lirilumab can be used in Leukemia, squamous cell carcinoma of the head and neck (SCCHN) research.

CAS-No: 1000676-41-4